Navigation Links
Spherix Reports 3rd Quarter Earnings
Date:11/16/2007

BELTSVILLE, Md., Nov. 16 /PRNewswire-FirstCall/ -- Spherix Incorporated (Nasdaq: SPEX) has reported a loss from continuing operations of $3.1 million ($0.22 per share) and $7.1 million ($0.50 per share) for the three- and nine- months ended September 30, 2007, respectively. These losses exceeded the losses for the corresponding periods of 2006 due to increased expenditures related to the Company's Phase 3 clinical trial of Naturlose as a treatment for type 2 diabetes. The Company anticipates the trial to continue through mid-2009. Income from discontinued operations was $8.4 million ($0.59 per share) in the third quarter of 2007, and $8.3 million ($0.59 per share) for the nine months ended September 30, 2007, reflecting the sale of the InfoSpherix subsidiary (see Spherix press release dated August 16, 2007). The Company's total net income was $5.3 million (37 cents per share) and $1.3 million (9 cents per shared), respectively for the three- and nine-months ended September 30, 2007.

Claire L. Kruger, CEO, said, "The sale of InfoSpherix has provided the Company with significant funding that will help us to pursue the Company's strategic interests."

Three months ended Nine months ended

September 30, September 30,

2007 2006 2007 2006

Revenue from continuing

operations $ 59,000 $ - $ 63,000 $ 3,000

Loss from continuing

operations $(3,122,000) $(981,000) $(7,063,000)$(2,350,000)

Income from discontinued

operations $ 8,416,000 $ 971,000 $ 8,321,000 $ 2,046,000

Net income
'/>"/>

SOURCE Spherix Incorporated
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Spherix Shareholders Support Companys Focus on Naturlose, Biotechnology
2. EpiCept Reports Expansion of Clinical Development For Licensed Cancer Compound
3. QMed, Inc. Reports July Medicare SNP Enrollments
4. Phlo Affiliate Reports Expanded Coverage to Oregon Border
5. Healthcare Technologies Reports Loss for 2007 Second Quarter & Six Months Results
6. Dragon Pharmaceutical Reports Growth in Sales and Profits during Second Quarter of 2007
7. Carrington Reports Second Quarter 2007 Results
8. Avitar Reports Third Quarter Financial Results for Fiscal 2007
9. Response Genetics Reports Second Quarter 2007 Financial Results
10. Cadence Pharmaceuticals Reports Second Quarter 2007 Financial Results
11. Transgenomic, Inc. Reports Second Quarter 2007 Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... SOUTH SAN FRANCISCO, Calif. , Sept. 2, 2015 ... announced that Bonnie H. Anderson , president and ... Global Healthcare Conference on Wednesday, September 16, 2015 at ... . The live audio webcast ... http://investor.veracyte.com . The webcast will be available shortly ...
(Date:9/2/2015)... Israel , September 2, 2015 ... intent of the National Institute of Allergy and Infectious Diseases ... within the Department of Health and Human Services (HHS), to ... the United States in the 2015-16 ... flu vaccine candidate, Multimeric-001 (M-001), as a primer vaccine, which ...
(Date:9/2/2015)... ... September 02, 2015 , ... ... aid high-risk surgeries. From vital sign monitoring in ICU to 3D skull printing ... surgeon to make real-time clinical decisions with simultaneous access to high precision medical ...
(Date:9/2/2015)... ... September 02, 2015 , ... Temarry Recycling's new ... waste to energy process and continue to contribute to the sustainability of our ... Waste to Energy process has been operating at their Mexico facility, Recicladora Temarry, ...
Breaking Biology Technology:Veracyte to Present at Morgan Stanley Global Healthcare Conference 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 2BiondVax Announces Intent to Launch a Phase 2 Trial in the United States in Collaboration with the U.S. National Institutes of Health 3Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 2Surgical Workstation Powered by 6th Gen. Intel® Core™ Skylake Processors 3Temarry Recycling’s New $100,000 Waste to Energy Renovation 2
... DIEGO, Feb. 9 PacificGMP, the leader ... for its client partners, announced today that ... LigoCyte Pharmaceuticals, Inc. Under the collaborative agreement, ... and will provide storage services under cGMP ...
... have made tremendous scientific advances by dissecting apart ... Researchers at the University of Wisconsin-Madison College of ... putting the pieces back together, mathematically. , John ... developed computer models of a relatively simple virus ...
... 6 MINRAD International,Inc. (Amex: BUF ) ... notice from,NYSE Alternext US LLC (the "Exchange") stating that ... Company from the Exchange by filing a delisting,application with ... the NYSE Alternext US Company Guide. By letter dated ...
Cached Biology Technology:PacificGMP and LigoCyte Pharmaceuticals Announce cGMP Manufacturing Collaboration 2Mathematical models reveal how organisms transcend the sum of their genes 2MINRAD Receives Notice That NYSE Alternext Intends to File Delisting Application With Securities and Exchange Commission 2MINRAD Receives Notice That NYSE Alternext Intends to File Delisting Application With Securities and Exchange Commission 3
(Date:8/31/2015)... , Aug. 31, 2015 Research and ... the "Saudi Arabia Biomedical Sensors Market - Growth, ... The Saudi Arabia Biomedical Sensors market ... CAGR of 3.64% over the period 2014-2020 ... adaptable to the genetic formulation of each individual. These ...
(Date:8/25/2015)... and BELLEVUE, Wash. , ... in advanced robotic systems, announced today it will unveil ... ground vehicle (UGV), at the National Tactical Officers Association ... The Guardian S is the first-ever commercially ... of years of research and in-field trials and is ...
(Date:8/20/2015)... Calif. , Aug. 20, 2015 ... on consumers that are active and healthy. However, ... in the hospital environment to help improve diagnostic ... a video from the Wearable Technologies Conference ... discussed new applications for wearables in healthcare.    ...
Breaking Biology News(10 mins):Saudi Arabia Biomedical Sensors Market Report 2015 - Growth, Trends & Forecasts (2014-2020) 2Sarcos to Debut First-of-its-Kind Snake Robot 2Sarcos to Debut First-of-its-Kind Snake Robot 3Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 2Leaf Healthcare Releases Video from Wearable Technology Conference on New Applications for Wearables in the Hospital Environment 3
... , March 18, 2013 Labrys Biologics Inc., a ... executive appointments to lead the development of RN-307, a Phase ... migraine. Marcelo Bigal, M.D., Ph.D., joins Labrys as chief medical ... as vice president of project management; Michele Bronson ...
... grasslands have been lost in just 10 years according to ... The seasonally flooded grasslands around the Tonle Sap, Southeast Asia,s ... a refuge for 11 globally-threatened bird species. They are also ... around 1.1 million people. Research published today in ...
... Calif. Models of carbon dioxide in the world,s oceans ... UC Irvine and other scientists published online Sunday in ... surface of warm waters are far more carbon-rich than ... fluctuations could mean that tiny Prochlorococcus and ...
Cached Biology News:Labrys Biologics Announces Key Executive Appointments 2Labrys Biologics Announces Key Executive Appointments 3Labrys Biologics Announces Key Executive Appointments 4UEA research reveals catastrophic loss of Cambodia's tropical flooded grasslands 2UEA research reveals catastrophic loss of Cambodia's tropical flooded grasslands 3Ocean plankton sponge up nearly twice the carbon currently assumed 2
EDTA, tetrasodium salt, 1 kg. Ethylene diaminetetraacetic acid.Dihydrate. Assay: 99-101% (as is).Risks: 36, 37, 38 ; Safety Precautions: 22, 36, 37. Category: Nucleotides & Enzymes & Biochemicals, Ul...
EDG-1 Western blot control Source: Cell Lysate Application: Western Blotting Control...
...
Kit containing positive control DNA all parts of the HIV-1 genome, HIV-1 negative control DNA, Primers SK38, SK39, SK19...
Biology Products: